← All drugs
Drug

Desonide

289 flagged reaction(s) · 13,593 total co-reports · max PRR 299.8
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Macular Degeneration 787 299.8 356.3 signal
2 Vaginal Discharge 153 65.5 67.6 signal
3 Paraesthesia Oral 200 59.8 62.3 signal
4 Oral Candidiasis 156 51.4 53.1 signal
5 Procedural Pain 183 28.2 29.3 signal
6 Frequent Bowel Movements 162 25.7 26.5 signal
7 Dermatitis Atopic 240 20.4 21.4 signal
8 Colitis 167 18.9 19.5 signal
9 Rectal Haemorrhage 173 17.1 17.6 signal
10 Therapeutic Product Effect Incomplete 264 15.9 16.7 signal
11 Colitis Ulcerative 166 15.8 16.3 signal
12 Sleep Disorder Due To A General Medical Condition 60 15.8 16.0 signal
13 Haematochezia 174 13.4 13.9 signal
14 Infusion Related Reaction 200 12.9 13.4 signal
15 Skin Fissures 50 11.2 11.4 signal
16 Eczema 129 10.9 11.2 signal
17 Dermatitis 52 10.7 10.8 signal
18 Conjunctivitis 45 10.4 10.5 signal
19 Psoriasis 284 9.2 9.7 signal
20 Skin Haemorrhage 30 8.8 8.9 signal
21 Dyspepsia 203 8.8 9.1 signal
22 Eye Pruritus 67 8.6 8.7 signal
23 Skin Exfoliation 163 8.3 8.6 signal
24 Scab 22 8.2 8.3 signal
25 Madarosis 21 7.6 7.6 signal
26 Eye Discharge 18 7.5 7.5 signal
27 Skin Infection 18 6.8 6.9 signal
28 Erythema 314 6.5 6.9 signal
29 Dermatitis Contact 17 6.4 6.4 signal
30 Psoriatic Arthropathy 60 6.3 6.4 signal
31 Dry Skin 182 5.9 6.1 signal
32 Skin Disorder 46 5.9 5.9 signal
33 Ocular Hyperaemia 64 5.8 5.9 signal
34 Dry Eye 65 5.7 5.8 signal
35 Neuralgia 31 5.4 5.4 signal
36 Impaired Quality Of Life 18 5.3 5.3 signal
37 Skin Lesion 34 5.3 5.3 signal
38 Tenderness 13 5.3 5.3 signal
39 Seasonal Allergy 17 5.1 5.1 signal
40 Pharyngitis Streptococcal 13 5.1 5.1 signal
41 Chronic Kidney Disease 92 5.1 5.2 signal
42 Pain Of Skin 31 4.9 4.9 signal
43 Basal Cell Carcinoma 17 4.6 4.6 signal
44 Product Dose Omission In Error 29 4.6 4.6 signal
45 Folliculitis 11 4.5 4.5 signal
46 Scratch 11 4.5 4.5 signal
47 Squamous Cell Carcinoma 10 4.5 4.5 signal
48 Eye Inflammation 10 4.5 4.5 signal
49 Eye Swelling 39 4.5 4.5 signal
50 Anaemia 197 4.4 4.5 signal
51 Oral Herpes 20 4.4 4.4 signal
52 Rash Pruritic 55 4.3 4.4 signal
53 Discomfort 61 4.3 4.3 signal
54 Weight Decreased 276 4.2 4.4 signal
55 Tooth Infection 13 4.2 4.2 signal
56 Therapeutic Response Shortened 31 4.1 4.1 signal
57 Therapeutic Response Decreased 58 4.1 4.1 signal
58 Constipation 207 4.1 4.2 signal
59 Abdominal Pain 222 4.0 4.2 signal
60 Sleep Disorder 66 4.0 4.0 signal
61 Eye Irritation 51 3.9 3.9 signal
62 Application Site Pain 20 3.9 3.9 signal
63 Pruritus 343 3.8 4.1 signal
64 Drug Ineffective 1,194 3.8 4.7 signal
65 Eye Infection 10 3.8 3.8 signal
66 Pyrexia 306 3.7 3.9 signal
67 Rash Macular 30 3.7 3.7 signal
68 Incorrect Product Administration Duration 17 3.6 3.6 signal
69 Sleep Apnoea Syndrome 16 3.5 3.6 signal
70 Ligament Sprain 8 3.4 3.4 signal
71 Lymphadenopathy 28 3.3 3.4 signal
72 Economic Problem 12 3.3 3.3 signal
73 Rotator Cuff Syndrome 10 3.3 3.3 signal
74 Bacteraemia 9 3.2 3.2 signal
75 End Stage Renal Disease 14 3.2 3.2 signal
76 Immune System Disorder 10 3.2 3.2 signal
77 Upper Respiratory Tract Infection 35 3.2 3.2 signal
78 Rash Papular 17 3.2 3.2 signal
79 Rash 328 3.2 3.4 signal
80 Ear Infection 20 3.2 3.2 signal
81 Intervertebral Disc Degeneration 7 3.2 3.2 signal
82 Rash Erythematous 35 3.2 3.2 signal
83 Arteriosclerosis 7 3.1 3.2 signal
84 Lacrimation Increased 22 3.1 3.1 signal
85 Coronary Artery Occlusion 10 3.1 3.1 signal
86 Dermatitis Allergic 9 3.1 3.1 signal
87 Osteopenia 11 3.1 3.1 signal
88 Vitreous Floaters 7 3.0 3.0 signal
89 Nerve Injury 8 3.0 3.0 signal
90 Anhedonia 19 3.0 3.0 signal
91 Lymphoma 11 3.0 3.0 signal
92 Rebound Effect 8 3.0 3.0 signal
93 Treatment Failure 57 2.9 3.0 signal
94 Neoplasm 8 2.9 2.9 signal
95 Ventricular Tachycardia 11 2.8 2.8 signal
96 Skin Burning Sensation 47 2.8 2.8 signal
97 Skin Discolouration 30 2.8 2.8 signal
98 Retinal Detachment 6 2.8 2.8 signal
99 Cardiomegaly 8 2.7 2.7 signal
100 Malaise 282 2.7 2.8 signal
101 Intervertebral Disc Protrusion 14 2.7 2.7 signal
102 Pain 391 2.7 2.8 signal
103 Oral Pain 14 2.6 2.6 signal
104 Sinusitis 64 2.6 2.7 signal
105 Coronary Artery Disease 19 2.6 2.6 signal
106 Ear Pain 12 2.6 2.6 signal
107 Thirst 11 2.6 2.6 signal
108 Sinus Disorder 12 2.6 2.6 signal
109 Therapy Partial Responder 9 2.5 2.5 signal
110 Hip Arthroplasty 9 2.5 2.5 signal
111 Tooth Abscess 6 2.5 2.5 no signal
112 Injection Site Discomfort 6 2.5 2.5 no signal
113 Spinal Operation 7 2.5 2.5 signal
114 Cellulitis 29 2.4 2.4 signal
115 Staphylococcal Infection 19 2.4 2.4 signal
116 Burning Sensation 40 2.4 2.4 signal
117 Product Use In Unapproved Indication 139 2.4 2.5 signal
118 Drug Eruption 10 2.4 2.4 signal
119 Incontinence 6 2.4 2.4 no signal
120 Bronchitis 42 2.4 2.4 signal
121 Haemorrhoids 11 2.4 2.4 signal
122 Gout 10 2.4 2.4 signal
123 Body Height Decreased 6 2.4 2.4 no signal
124 Renal Failure 74 2.3 2.4 signal
125 Osteomyelitis 10 2.3 2.3 signal
126 Inflammation 28 2.3 2.3 signal
127 Eye Pain 30 2.3 2.3 signal
128 Appendicitis 5 2.3 2.3 no signal
129 Middle Insomnia 10 2.3 2.3 signal
130 Photophobia 10 2.3 2.3 signal
131 Tubulointerstitial Nephritis 10 2.3 2.3 signal
132 Nephropathy 5 2.3 2.3 no signal
133 Face Oedema 9 2.3 2.3 signal
134 Nasal Congestion 31 2.2 2.3 signal
135 Laceration 5 2.2 2.2 no signal
136 Malignant Melanoma 7 2.2 2.2 no signal
137 Metastases To Lung 6 2.2 2.2 no signal
138 Glaucoma 10 2.2 2.2 signal
139 Tendonitis 8 2.2 2.2 no signal
140 Decreased Immune Responsiveness 5 2.2 2.2 no signal
141 Viral Infection 17 2.2 2.2 signal
142 Headache 320 2.2 2.2 signal
143 Kidney Infection 10 2.2 2.2 signal
144 Blood Iron Decreased 6 2.2 2.2 no signal
145 Inflammatory Bowel Disease 5 2.2 2.2 no signal
146 Cyanosis 8 2.2 2.2 no signal
147 Application Site Rash 7 2.1 2.2 no signal
148 Product Prescribing Error 12 2.1 2.2 signal
149 Wrist Fracture 6 2.1 2.1 no signal
150 Pneumocystis Jirovecii Pneumonia 5 2.1 2.1 no signal
151 Urticaria 83 2.1 2.1 signal
152 Ovarian Cyst 5 2.1 2.1 no signal
153 Drug Effect Less Than Expected 7 2.1 2.1 no signal
154 Toxic Skin Eruption 5 2.1 2.1 no signal
155 Hypersomnia 14 2.1 2.1 signal
156 Emotional Distress 59 2.1 2.1 signal
157 Secretion Discharge 6 2.1 2.1 no signal
158 Off Label Use 420 2.1 2.1 signal
159 Febrile Neutropenia 32 2.0 2.1 signal
160 Pharyngitis 6 2.0 2.0 no signal
161 Limb Injury 13 2.0 2.0 signal
162 Pulmonary Hypertension 10 2.0 2.0 signal
163 Swelling Face 31 2.0 2.0 signal
164 Full Blood Count Abnormal 5 2.0 2.0 no signal
165 Arthritis 37 2.0 2.0 no signal
166 Irritable Bowel Syndrome 10 2.0 2.0 no signal
167 Renal Injury 14 2.0 2.0 no signal
168 Platelet Count Increased 6 1.9 1.9 no signal
169 Inappropriate Schedule Of Product Administration 80 1.9 1.9 no signal
170 Joint Range Of Motion Decreased 6 1.9 1.9 no signal
171 Alopecia 88 1.9 1.9 no signal
172 Stress 32 1.9 1.9 no signal
173 Hair Texture Abnormal 6 1.9 1.9 no signal
174 Uveitis 6 1.9 1.9 no signal
175 Fistula 5 1.9 1.9 no signal
176 Sinus Congestion 6 1.9 1.9 no signal
177 Toothache 8 1.9 1.9 no signal
178 Skin Irritation 20 1.8 1.9 no signal
179 Diverticulitis 12 1.8 1.8 no signal
180 Muscle Tightness 7 1.8 1.8 no signal
181 Tooth Loss 9 1.8 1.8 no signal
182 Back Disorder 7 1.8 1.8 no signal
183 Eye Disorder 14 1.8 1.8 no signal
184 Abortion Induced 4 1.8 1.8 no signal
185 Injection Site Reaction 29 1.8 1.8 no signal
186 Spinal Disorder 4 1.8 1.8 no signal
187 Oropharyngeal Pain 39 1.8 1.8 no signal
188 Injection Site Pruritus 28 1.8 1.8 no signal
189 Influenza 47 1.8 1.8 no signal
190 Skin Cancer 9 1.8 1.8 no signal
191 Localised Infection 10 1.8 1.8 no signal
192 Bone Density Decreased 13 1.7 1.7 no signal
193 Illness 41 1.7 1.7 no signal
194 Angioedema 18 1.7 1.7 no signal
195 Insurance Issue 6 1.7 1.7 no signal
196 Tooth Extraction 5 1.7 1.7 no signal
197 Osteonecrosis Of Jaw 10 1.7 1.7 no signal
198 Migraine 38 1.7 1.7 no signal
199 Upper Limb Fracture 8 1.7 1.7 no signal
200 Herpes Zoster 23 1.7 1.7 no signal
201 Exposure Via Skin Contact 9 1.7 1.7 no signal
202 Hair Colour Changes 5 1.7 1.7 no signal
203 Application Site Pruritus 9 1.7 1.7 no signal
204 Injection Site Rash 12 1.7 1.7 no signal
205 Bone Loss 6 1.7 1.7 no signal
206 Initial Insomnia 4 1.7 1.7 no signal
207 Osteonecrosis 13 1.7 1.7 no signal
208 Drug Level Decreased 4 1.7 1.7 no signal
209 Ear Discomfort 4 1.7 1.7 no signal
210 Product Dose Omission Issue 111 1.7 1.7 no signal
211 Injection Site Warmth 8 1.6 1.6 no signal
212 Nodule 5 1.6 1.6 no signal
213 Bedridden 5 1.6 1.6 no signal
214 Surgery 22 1.6 1.6 no signal
215 Injection Site Pain 114 1.6 1.6 no signal
216 Injection Site Urticaria 9 1.6 1.6 no signal
217 Injection Site Swelling 28 1.6 1.6 no signal
218 Ocular Discomfort 4 1.6 1.6 no signal
219 Pruritus Generalised 8 1.5 1.5 no signal
220 Skin Reaction 5 1.5 1.5 no signal
221 Impaired Driving Ability 4 1.5 1.5 no signal
222 Mental Disorder 15 1.5 1.5 no signal
223 Arthropathy 19 1.4 1.4 no signal
224 Product Preparation Error 7 1.4 1.4 no signal
225 Withdrawal Syndrome 14 1.4 1.4 no signal
226 Expired Product Administered 11 1.4 1.4 no signal
227 Unevaluable Event 25 1.4 1.4 no signal
228 Blood Count Abnormal 5 1.4 1.4 no signal
229 Tendon Rupture 4 1.4 1.4 no signal
230 Emotional Disorder 10 1.4 1.4 no signal
231 Application Site Irritation 4 1.4 1.4 no signal
232 Injection Site Irritation 4 1.3 1.3 no signal
233 Therapeutic Product Effect Decreased 14 1.3 1.3 no signal
234 Affect Lability 3 1.3 1.3 no signal
235 Injection Site Induration 4 1.3 1.3 no signal
236 Application Site Erythema 8 1.3 1.3 no signal
237 Product Physical Issue 6 1.3 1.3 no signal
238 Activities Of Daily Living Impaired 6 1.3 1.3 no signal
239 Injection Site Mass 11 1.3 1.3 no signal
240 Product Prescribing Issue 6 1.2 1.2 no signal
241 Incorrect Dose Administered 66 1.2 1.2 no signal
242 Product Dose Omission 19 1.2 1.2 no signal
243 Eosinophilia 5 1.2 1.2 no signal
244 Systemic Lupus Erythematosus 10 1.2 1.2 no signal
245 Acne 21 1.2 1.2 no signal
246 Colon Cancer 4 1.1 1.1 no signal
247 Injection Site Bruising 21 1.1 1.1 no signal
248 Maternal Exposure During Pregnancy 23 1.1 1.1 no signal
249 Injection Site Erythema 32 1.1 1.1 no signal
250 Cytopenia 3 1.1 1.1 no signal
251 Pregnancy 5 1.0 1.0 no signal
252 Hepatic Cytolysis 3 1.0 1.0 no signal
253 Mania 4 1.0 1.0 no signal
254 Libido Decreased 3 1.0 1.0 no signal
255 Injection Site Discolouration 3 1.0 1.0 no signal
256 Pemphigus 3 1.0 1.0 no signal
257 Neoplasm Malignant 16 1.0 1.0 no signal
258 Anger 8 1.0 1.0 no signal
259 Intraocular Pressure Increased 3 1.0 1.0 no signal
260 Ankylosing Spondylitis 3 1.0 1.0 no signal
261 Product Dispensing Error 5 1.0 1.0 no signal
262 Syringe Issue 4 1.0 1.0 no signal
263 Extra Dose Administered 9 1.0 1.0 no signal
264 Synovitis 4 0.9 0.9 no signal
265 Drug Effect Incomplete 8 0.9 0.9 no signal
266 Incorrect Drug Administration Duration 6 0.9 0.9 no signal
267 Accidental Exposure To Product 21 0.9 0.9 no signal
268 Drug Effect Decreased 11 0.9 0.9 no signal
269 Glycosylated Haemoglobin Increased 5 0.8 0.8 no signal
270 Drug Dose Omission 33 0.8 0.8 no signal
271 Vaginal Haemorrhage 8 0.8 0.8 no signal
272 Multiple Fractures 3 0.8 0.8 no signal
273 Plasma Cell Myeloma 7 0.8 0.8 no signal
274 Injection Site Haemorrhage 14 0.7 0.7 no signal
275 Drug Effective For Unapproved Indication 5 0.7 0.7 no signal
276 Multiple Sclerosis 8 0.7 0.7 no signal
277 Incorrect Dose Administered By Device 4 0.7 0.7 no signal
278 Drug Prescribing Error 3 0.7 0.7 no signal
279 Menorrhagia 3 0.6 0.6 no signal
280 Abortion Spontaneous 6 0.6 0.6 no signal
281 Pancreatic Carcinoma 4 0.6 0.6 no signal
282 Breast Cancer 11 0.5 0.5 no signal
283 Device Issue 10 0.5 0.5 no signal
284 Menstruation Irregular 3 0.5 0.5 no signal
285 Drug Withdrawal Syndrome 10 0.5 0.5 no signal
286 Incorrect Route Of Drug Administration 4 0.5 0.5 no signal
287 Drug Exposure During Pregnancy 3 0.4 0.4 no signal
288 Drug Dependence 14 0.4 0.4 no signal
289 Bladder Cancer 3 0.2 0.2 no signal